Haberler2016 “TÜBA Ödülleri” Sahiplerini Buldu TÜBA Uluslararası Akademi Ödülü Sahibi Prof. Dr. Omar M. Yaghi’den Konferans TÜBA Asosye Üyesi Doç Dr. Demirköz, GYA Üyesi Seçildi “TÜBA V. Uygulamalı Bilim Eğitimi Kursu” İstanbul Üniversitesi’nde Gerçekleştirildi TÜBA Başkanı Prof. Acar ve Konsey Üyeleri Prof. Keleştemur ve Prof. Şeker, Akademi Şeref Üyesi Prof. Sezgin’i Ziyaret Etti İstanbul Ticaret Üniversitesi Rektörü Prof. Ekren, TÜBA Başkanı Prof. Acar’ı Ziyaret Etti Kastamonu Belediye Başkanı Tahsin Babaş ve Beraberindeki Heyet TÜBA Başkanı Prof. Acar’ı Ziyaret Etti Japonya Büyükelçisi Oka ve STS Başkanı Omi, TÜBA Başkanı Prof. Acar’ı Ziyaret Etti Hasan Kalyoncu Üniversitesi Rektörü Prof. Yılmaz’dan TÜBA’ya Ziyaret TÜBA-AR ve TÜBA-KED Ağ Sayfaları Hizmete Açıldı
TÜBA Phase Studies and Ethical Rules Workshop on Clinical Studies
Tarih: 09 OCAK 2017 Okunma Sayısı: 1486
"Phase Studies and Ethical Rules Workshop on Clinical Studies" organized by TÜBA will be held on January 13-14, 2017 at The Green Park Hotel, Pendik, Istanbul.
12 different topics including patient and public awareness, studies conducted on animals, cellular therapy and regenerative medicine, ethical rules in studies conducted with biosimilar drugs, non-drug clinical studies will be examined with the participation of around 200 scientists and administrators at the workshop.
TÜBA President Prof. Ahmet Cevat Acar said that the main objective of the workshop is to contribute to the conduct of clinical studies in Turkey in accordance with the relevant rules and that it is important to increase the scientific impact of Turkey in the world, to develop our national drug industry, to produce biosimilar products and to use international research funds.
TÜBA President Prof. Acar "There are important problems in our country related to clinical studies"
The report to be published at the end of the workshop prepared with the contribution of relevant working groups, members and stakeholders representatives will be sent to the relevant public institutions and organizations, the Ministry of Health, SGK and its affiliates, universities and the administrators of public hospitals.